FDA asked to require warnings on DTC ads for implanted devices

Long, Don
January 2008
Biomedical Business & Technology;Jan2008, Vol. 31 Issue 1, p26
The article reports on a petition to require warnings on direct-to-consumer (DTC) advertising for implanted devices filed by the Washington-based Consumers Union (CU) to the U.S. Food and Drug Administration (FDA). The CU calls for the inclusion of warnings about the possibility of dangerous infections or failures of the devices once inside the body. The organization stresses that most advertisements lack basic information on its potential adverse effects. The petition aims to minimize the unintended side effects of the devices.


Related Articles

  • DTC device ads have merit. Hempstead, Susan // Medical Marketing & Media;Jan2006, Vol. 41 Issue 1, p93 

    The article reports that the U.S. Food and Drug Administration (FDA) has sponsored a series of public meetings to solicit information and views about direct-to-consumer (DTC) promotion of prescription drug products through print, broadcast or other types of media. DTC media-product...

  • Turf War Escalates Over Big Pharma Marketing. Edwards, Jim // Brandweek;11/7/2005, Vol. 46 Issue 40, p6 

    This article focuses on the efforts of the U.S. Food and Drug Administration to review policies on direct-to-consumer (DTC) drug advertising as of November 2005. The policies were brought about by the pleas of parties wanting to ban DTC advertising. While no marketer proposed a total advertising...

  • NOTHING BUT BLUE SKIES? Thomaselli, Rich // Advertising Age;10/2/2006, Vol. 77 Issue 40, p3 

    The article focuses on the status of direct-to-consumer (DTC) television advertising from drug companies in the U.S. Since the Food and Drug Administration's decision to relax the guidelines regarding DTC advertisements, the category has emerged from a dawdling $12 million business to a $4.1...

  • Presenting Risk in Drug Advertising. Heisey, Colleen; Chernove, Arianna // Contract Pharma;Sep2010, Vol. 12 Issue 7, p18 

    The article focuses on the publication of a proposed rule by the U.S. Food and Drug Administration (FDA) that is aimed for the amendment of radio and television direct-to-consumer (DTC) advertising regulations for prescription drugs. The amendment seeks to include standards by which FDA will...

  • Congress eyes restrictions on DTC, med ed. Arnold, Matthew // Medical Marketing & Media;Mar2007, Vol. 42 Issue 3, p30 

    The article reports on the legislative bill co-authored by Senators Ted Kennedy and Mike Enzi that calls for improvement in the monitoring of drug safety in the U.S. The bill would set a two-year moratorium on direct-to-consumer (DTC) prescription drug advertising and require the Food and Drug...

  • Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising Has Limitations: GAO-03-177.  // GAO Reports;10/28/2002, p1 

    Prescription drug spending increased at an annual rate of 18 percent from 1997 through 2001 and is the fastest growing component of health care spending in the United States. Among the many reasons cited for this increase are growth in the number of patients diagnosed with conditions that can be...

  • FDA revisits DTC advertising. Young, Donna // American Journal of Health-System Pharmacy;12/15/2005, Vol. 62 Issue 24, p2580 

    The article reports on the re-evaluation conducted by the Food & Drug Administration (FDA) on the implementation of direct-to-consumer prescription drug advertising in the U.S. The agency is considering whether to impose stricter requirements for medication commercials aimed at consumers. A...

  • Legislators may move on DTC drug advertising. Goetzl, David; Teinowitz, Ira // Advertising Age;4/2/2001, Vol. 72 Issue 14, p3 

    Discusses direct-to-consumer (DTC) drug advertising in the United States. There is a possibility of legislation to set advertising standards. Factors that influence the high cost of prescription drugs are discussed. The loosening of regulations by the U.S. Food and Drug Administration have...

  • DTC Advertising Under Fire. Wechsler, Jill // Pharmaceutical Executive;Jan2009, Vol. 29 Issue 1, p14 

    The article focuses on the support of Representative Henry Waxman to a legislative bill that allows the Food & Drug Administration (FDA) to check diret-to-consumer (DTC) advertising on certain approved drugs in the U.S. Waxman illustrates that the goal of the said legislation is to strengthen...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics